Medication-info.com Search Menu

Conjupri (Levamlodipine maleate): Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx)
Strength:
2.5 mg, 5 mg
Active ingredient:

Patient information: uses, side effects, how to take - Conjupri

What is CONJUPRI ®?

CONJUPRI ® is a prescription medicine used to treat high blood pressure (hypertension) in adults and pediatric patients 6 years and older. CONJUPRI ® can be used by itself or with other high blood pressure medicines.

It is not known if CONJUPRI ® is safe and effective in children less than 6 years of age.

Do not take CONJUPRI ® if you are allergic to amlodipine or to any of the ingredients in CONJUPRI ®. See the end of this Patient Information for a complete list of ingredients in CONJUPRI ®.

Before taking CONJUPRI ®, tell your healthcare provider about all of your medical conditions, including if you:

  • have heart problems
  • have liver problems
  • are pregnant or plan to become pregnant. It is not known if CONJUPRI ® can harm your unborn baby. Tell your healthcare provider if you become pregnant during treatment with CONJUPRI ®.

  • are breastfeeding or plan to breastfeed. CONJUPRI ® can pass into your breast milk. Talk to your healthcare provider about the best way to feed your baby during treatment with CONJUPRI ®.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

How should I take CONJUPRI ®?

  • Take CONJUPRI ® exactly as your healthcare provider tell you to.
  • Take CONJUPRI ® 1 time a day.
  • If you take too much CONJUPRI ®, contact your local poison control center or go to the nearest hospital emergency room right away.

What are the possible side effects of CONJUPRI ®?

CONJUPRI ® may cause serious side effects, including :

  • Low blood pressure (hypotension). CONJUPRI ® may cause low blood pressure, especially in people that have a condition called severe aortic stenosis. Tell your healthcare provider if you feel faint or lightheaded.
  • Worsening chest pain (angina) or heart attack. CONJUPRI ® may cause worsening chest pain or heart attack after starting or increasing your dose, especially in people with a condition called severe obstructive coronary artery disease. If that happens, call your healthcare provider right away or go directly to a hospital emergency room.

The most common side effects of CONJUPRI ® include:

  • swelling of your legs or ankles
  • tiredness
  • nausea
  • stomach pain
  • sleepiness
  • dizziness
  • flushing (hot or warm feeling in your face)
  • heart palpitations (very fast heartbeat)

These are not all of the possible side effects of CONJUPRI ®.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

How should I store CONJUPRI ®?

  • Store CONJUPRI ® at 68°F to 77°F (20°C to 25°C).
  • Keep CONJUPRI ® out of the light.

Keep CONJUPRI ® and all medicines out of the reach of children.

General information about the safe and effective use of CONJUPRI ®.

Medicines are sometimes prescribed for purposes other than those listed in a Patient Information leaflet. Do not use CONJUPRI ® for a condition for which it was not prescribed. Do not give CONJUPRI ® to other people, even if they have the same symptoms that you have. It may harm them. You can ask your pharmacist or healthcare provider for information about CONJUPRI ® that is written for health professionals.

What are the ingredients in CONJUPRI ®?

Active ingredient: levamlodipine maleate

Inactive ingredients: betadex, colloidal silicon dioxide, magnesium stearate, microcrystalline cellulose, and pregelatinized starch

Manufactured by:

CSPC Ouyi Pharmaceutical Co., Ltd.

Shijiazhuang, Hebei, China, 052160

Distributed by:

WraSer Pharmaceuticals LLC

Ridgeland, MS 39157

CONJUPRI ® is a registered trademark of CSPC Ouyi Pharmaceutical Co., Ltd.

© 2021 CSPC Ouyi Pharmaceutical Co., Ltd.

For more information, call Toll Free number 1-888-252-3901

About this document

Source: FDA drug labeling via NLM DailyMed · Application number: NDA 212895 · View the label on DailyMed

Revision date stated in the text: August 2021

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Conjupri

Rx or OTC
Prescription (Rx)?
  • This drug is available only with a prescription from a licensed healthcare provider.
  • Rx
Active ingredient Levamlodipine maleate
Dosage form Tablet
Route Oral
Marketing status not in the current FDA NDC Directory
Company (applicant) CSPC OUYI
FDA approval NDA 212895New Drug Application (NDA) Approved December 19, 2019
Reference listed drug This is the reference listed drug (RLD) that generics are compared with.
Manufacturers 2 labelers list this drug on DailyMed
Packages (NDC)
Package
2.5 mg – 30 in 1 bottle NDC 66992-425-30
5 mg – 30 in 1 bottle NDC 66992-430-30

Source: FDA drug labeling via NLM DailyMed, data as of October 31, 2026. FDA data (DailyMed, Orange Book, Drug Shortages, enforcement reports). Not a substitute for the advice of a doctor or pharmacist.